How Bristol Myers Squibb Is Accelerating Drug...

Snap processes more than 10 petabytes of experimentation data every single morning—and with NVIDIA GPU-accelerated Apache Spark on Google Cloud, Snap cut job costs by 76%, reduced memory usage by 80%, and eliminated 120 terabytes of disk spill from its pipelines. Prudhvi Vatala, ...  عرض المزيد

LangChain has surpassed 1 billion downloads—and the framework that started as a weekend project is now the harness powering the next generation of production-grade AI agents. In this episode, Harrison Chase, co-founder & CEO of LangChain, breaks down the architecture behind deep ...  عرض المزيد

Can AI compress the years long research time of a PhD into seconds? Research scientist Max Jaderberg explores how “AI analogs” simulate real-world lab work with staggering speed and scale, unlocking new insights on protein folding and drug discovery. Drawing on his experience wor ...  عرض المزيد

Bringing new drugs to market is a costly, time-consuming endeavor. On top of that, most medicines fail at some point in the research and development phase. Sarah Guo is joined by Sajith Wickramasekara, co-founder and CEO of Benchling, a company that has not only become the centra ...  عرض المزيد

GSK’s Chief Digital and Technology Officer Shobie Ramakrishnan discusses how the company is leveraging AI and data models for vaccine development and drug discovery in this episode of Bloomberg Intelligence’s Tech Disruptors podcast. BI’s Health-Care Analyst Sam Fazeli and Techno ...  عرض المزيد

In this episode of NEJM AI Grand Rounds, hosts Raj Manrai and Andy Beam interview Dr. David Ouyang, a cardiologist and AI researcher at Cedars-Sinai Medical Center. The conversation explores Ouyang’s journey from ...